Big Pharma eyes up Pharmac in trade talks

By Ruth Laugesen In Commentary

Print Share
11th June, 2011
Pharmac used to be as popular as vermin. Think back to Herceptin and the cancer-stricken women who protested against Pharmac for denying them subsidised year-long courses of the drug and perhaps another chance at life. Back then, Pharmac was treating New Zealand women like “lab rats”, according to the Breast Cancer Aotearoa Coalition. It was offering treatment that was “unproven, unsafe and cheap”, said National MP Dr Jackie Blue, a specialist in the area of breast cancer, by funding a nine-week but not a 12-month course of Herceptin. It was subjecting New Zealand women to what might ...

NZ Listener print only subscriptions & digital only subscriptions

NZ Listener subscriptions;

Print subscriptions: To receive the NZ Listener in your mailbox each week click here.

Digital subscriptions: We now have the NZ Listener weekly edition as a digital reader version via the Zinio digital platform – read the latest edition on your computer or via the Zinio app on your tablet.  To find our more click here.

Archive content: If you’re interested in accessing archive content, please contact our NZ Listener helpdesk contact us.  We endeavor to get back to you within 5 working days.

Locked content: If you have an archive content login, please login to view and unlock content, for more information regarding locked content please read our NZ Listener FAQ’s

Any queries regarding access please contact our NZ Listener helpdesk contact us.

More by Ruth Laugesen

Switch to our mobile site